Renal tumor in developing countries: 142 cases from a single institution at Shanghai, China
Background The clinical management of children with renal tumors including Wilms’ tumor, clear cell sarcoma, rhabdoid tumor and other renal tumors in our center was designed according to the National Wilms’ Tumor Study Group protocols. Methods A total of 142 consecutive patients who had been diagnos...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Pan, Ci [verfasserIn] Cai, Jiao-Yang [verfasserIn] Xu, Min [verfasserIn] Ye, Qi-Dong [verfasserIn] Zhou, Min [verfasserIn] Yin, Min-Zhi [verfasserIn] Zhong, Yu-Min [verfasserIn] Chen, Jing [verfasserIn] Shen, Shu-Hong [verfasserIn] Tang, Jing-Yan [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2015 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
Enthalten in: World Journal of Pediatrics - Springer-Verlag, 2008, 11(2015), 4 vom: 11. Okt., Seite 326-330 |
|---|---|
| Übergeordnetes Werk: |
volume:11 ; year:2015 ; number:4 ; day:11 ; month:10 ; pages:326-330 |
| Links: |
|---|
| DOI / URN: |
10.1007/s12519-015-0041-3 |
|---|
| Katalog-ID: |
SPR025994387 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR025994387 | ||
| 003 | DE-627 | ||
| 005 | 20201125083906.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201007s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s12519-015-0041-3 |2 doi | |
| 035 | |a (DE-627)SPR025994387 | ||
| 035 | |a (SPR)s12519-015-0041-3-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Pan, Ci |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Renal tumor in developing countries: 142 cases from a single institution at Shanghai, China |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Background The clinical management of children with renal tumors including Wilms’ tumor, clear cell sarcoma, rhabdoid tumor and other renal tumors in our center was designed according to the National Wilms’ Tumor Study Group protocols. Methods A total of 142 consecutive patients who had been diagnosed as having renal tumors at Shanghai Children’s Medical Center were reviewed retrospectively in the period of December 1998 and September 2012. Diagnosis and treatment were decided by a multidisciplinary team including oncologists, surgeons, pathologists and sub-specialized radiologists. Results The median age of the patients at the time of diagnosis was 27 months. The tumor stages of the patients were as follows: stage I 24.6%, stage II 23.2%, stage III 32.3%, stage IV 14.1%, and stage V 5.6%. Favorable histology was diagnosed in 80.3%, anaplasia in 4.2%, clear cell sarcoma in 9.8%, rhabdoid tumor in 4.9%, and other renal tumors in 0.7% of the patients. The eventfree and overall 5-year survival rates were 80% and 83%, respectively. Tumor relapse and progress was seen in 25 patients (17.6%). The median relapse time was 6 months (range: 2-37 months). Seven relapsing patients were retreated and four of them got second complete remission (three in stage II, one in stage I). Conclusion A multi-disciplinary team work model is feasible in developing countries, and the renal tumors protocols basically from developed countries are safe in developing countries. | ||
| 650 | 4 | |a China |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a developing country |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a multi-disciplinary team |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a renal tumors |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Cai, Jiao-Yang |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Min |e verfasserin |4 aut | |
| 700 | 1 | |a Ye, Qi-Dong |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Min |e verfasserin |4 aut | |
| 700 | 1 | |a Yin, Min-Zhi |e verfasserin |4 aut | |
| 700 | 1 | |a Zhong, Yu-Min |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Jing |e verfasserin |4 aut | |
| 700 | 1 | |a Shen, Shu-Hong |e verfasserin |4 aut | |
| 700 | 1 | |a Tang, Jing-Yan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t World Journal of Pediatrics |d Springer-Verlag, 2008 |g 11(2015), 4 vom: 11. Okt., Seite 326-330 |w (DE-627)SPR02598876X |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2015 |g number:4 |g day:11 |g month:10 |g pages:326-330 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s12519-015-0041-3 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a GBV_ILN_21 | ||
| 912 | |a GBV_ILN_31 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_61 | ||
| 912 | |a GBV_ILN_62 | ||
| 912 | |a GBV_ILN_63 | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a GBV_ILN_66 | ||
| 912 | |a GBV_ILN_69 | ||
| 912 | |a GBV_ILN_92 | ||
| 912 | |a GBV_ILN_135 | ||
| 912 | |a GBV_ILN_181 | ||
| 912 | |a GBV_ILN_192 | ||
| 912 | |a GBV_ILN_211 | ||
| 912 | |a GBV_ILN_252 | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2015 |e 4 |b 11 |c 10 |h 326-330 | ||
| author_variant |
c p cp j y c jyc m x mx q d y qdy m z mz m z y mzy y m z ymz j c jc s h s shs j y t jyt |
|---|---|
| matchkey_str |
pancicaijiaoyangxuminyeqidongzhouminyinm:2015----:eatmrneeoigonre12aefoaigentt |
| hierarchy_sort_str |
2015 |
| publishDate |
2015 |
| allfields |
10.1007/s12519-015-0041-3 doi (DE-627)SPR025994387 (SPR)s12519-015-0041-3-e DE-627 ger DE-627 rakwb eng Pan, Ci verfasserin aut Renal tumor in developing countries: 142 cases from a single institution at Shanghai, China 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background The clinical management of children with renal tumors including Wilms’ tumor, clear cell sarcoma, rhabdoid tumor and other renal tumors in our center was designed according to the National Wilms’ Tumor Study Group protocols. Methods A total of 142 consecutive patients who had been diagnosed as having renal tumors at Shanghai Children’s Medical Center were reviewed retrospectively in the period of December 1998 and September 2012. Diagnosis and treatment were decided by a multidisciplinary team including oncologists, surgeons, pathologists and sub-specialized radiologists. Results The median age of the patients at the time of diagnosis was 27 months. The tumor stages of the patients were as follows: stage I 24.6%, stage II 23.2%, stage III 32.3%, stage IV 14.1%, and stage V 5.6%. Favorable histology was diagnosed in 80.3%, anaplasia in 4.2%, clear cell sarcoma in 9.8%, rhabdoid tumor in 4.9%, and other renal tumors in 0.7% of the patients. The eventfree and overall 5-year survival rates were 80% and 83%, respectively. Tumor relapse and progress was seen in 25 patients (17.6%). The median relapse time was 6 months (range: 2-37 months). Seven relapsing patients were retreated and four of them got second complete remission (three in stage II, one in stage I). Conclusion A multi-disciplinary team work model is feasible in developing countries, and the renal tumors protocols basically from developed countries are safe in developing countries. China (dpeaa)DE-He213 developing country (dpeaa)DE-He213 multi-disciplinary team (dpeaa)DE-He213 renal tumors (dpeaa)DE-He213 Cai, Jiao-Yang verfasserin aut Xu, Min verfasserin aut Ye, Qi-Dong verfasserin aut Zhou, Min verfasserin aut Yin, Min-Zhi verfasserin aut Zhong, Yu-Min verfasserin aut Chen, Jing verfasserin aut Shen, Shu-Hong verfasserin aut Tang, Jing-Yan verfasserin aut Enthalten in World Journal of Pediatrics Springer-Verlag, 2008 11(2015), 4 vom: 11. Okt., Seite 326-330 (DE-627)SPR02598876X nnns volume:11 year:2015 number:4 day:11 month:10 pages:326-330 https://dx.doi.org/10.1007/s12519-015-0041-3 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_21 GBV_ILN_31 GBV_ILN_40 GBV_ILN_61 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_66 GBV_ILN_69 GBV_ILN_92 GBV_ILN_135 GBV_ILN_181 GBV_ILN_192 GBV_ILN_211 GBV_ILN_252 AR 11 2015 4 11 10 326-330 |
| spelling |
10.1007/s12519-015-0041-3 doi (DE-627)SPR025994387 (SPR)s12519-015-0041-3-e DE-627 ger DE-627 rakwb eng Pan, Ci verfasserin aut Renal tumor in developing countries: 142 cases from a single institution at Shanghai, China 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background The clinical management of children with renal tumors including Wilms’ tumor, clear cell sarcoma, rhabdoid tumor and other renal tumors in our center was designed according to the National Wilms’ Tumor Study Group protocols. Methods A total of 142 consecutive patients who had been diagnosed as having renal tumors at Shanghai Children’s Medical Center were reviewed retrospectively in the period of December 1998 and September 2012. Diagnosis and treatment were decided by a multidisciplinary team including oncologists, surgeons, pathologists and sub-specialized radiologists. Results The median age of the patients at the time of diagnosis was 27 months. The tumor stages of the patients were as follows: stage I 24.6%, stage II 23.2%, stage III 32.3%, stage IV 14.1%, and stage V 5.6%. Favorable histology was diagnosed in 80.3%, anaplasia in 4.2%, clear cell sarcoma in 9.8%, rhabdoid tumor in 4.9%, and other renal tumors in 0.7% of the patients. The eventfree and overall 5-year survival rates were 80% and 83%, respectively. Tumor relapse and progress was seen in 25 patients (17.6%). The median relapse time was 6 months (range: 2-37 months). Seven relapsing patients were retreated and four of them got second complete remission (three in stage II, one in stage I). Conclusion A multi-disciplinary team work model is feasible in developing countries, and the renal tumors protocols basically from developed countries are safe in developing countries. China (dpeaa)DE-He213 developing country (dpeaa)DE-He213 multi-disciplinary team (dpeaa)DE-He213 renal tumors (dpeaa)DE-He213 Cai, Jiao-Yang verfasserin aut Xu, Min verfasserin aut Ye, Qi-Dong verfasserin aut Zhou, Min verfasserin aut Yin, Min-Zhi verfasserin aut Zhong, Yu-Min verfasserin aut Chen, Jing verfasserin aut Shen, Shu-Hong verfasserin aut Tang, Jing-Yan verfasserin aut Enthalten in World Journal of Pediatrics Springer-Verlag, 2008 11(2015), 4 vom: 11. Okt., Seite 326-330 (DE-627)SPR02598876X nnns volume:11 year:2015 number:4 day:11 month:10 pages:326-330 https://dx.doi.org/10.1007/s12519-015-0041-3 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_21 GBV_ILN_31 GBV_ILN_40 GBV_ILN_61 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_66 GBV_ILN_69 GBV_ILN_92 GBV_ILN_135 GBV_ILN_181 GBV_ILN_192 GBV_ILN_211 GBV_ILN_252 AR 11 2015 4 11 10 326-330 |
| allfields_unstemmed |
10.1007/s12519-015-0041-3 doi (DE-627)SPR025994387 (SPR)s12519-015-0041-3-e DE-627 ger DE-627 rakwb eng Pan, Ci verfasserin aut Renal tumor in developing countries: 142 cases from a single institution at Shanghai, China 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background The clinical management of children with renal tumors including Wilms’ tumor, clear cell sarcoma, rhabdoid tumor and other renal tumors in our center was designed according to the National Wilms’ Tumor Study Group protocols. Methods A total of 142 consecutive patients who had been diagnosed as having renal tumors at Shanghai Children’s Medical Center were reviewed retrospectively in the period of December 1998 and September 2012. Diagnosis and treatment were decided by a multidisciplinary team including oncologists, surgeons, pathologists and sub-specialized radiologists. Results The median age of the patients at the time of diagnosis was 27 months. The tumor stages of the patients were as follows: stage I 24.6%, stage II 23.2%, stage III 32.3%, stage IV 14.1%, and stage V 5.6%. Favorable histology was diagnosed in 80.3%, anaplasia in 4.2%, clear cell sarcoma in 9.8%, rhabdoid tumor in 4.9%, and other renal tumors in 0.7% of the patients. The eventfree and overall 5-year survival rates were 80% and 83%, respectively. Tumor relapse and progress was seen in 25 patients (17.6%). The median relapse time was 6 months (range: 2-37 months). Seven relapsing patients were retreated and four of them got second complete remission (three in stage II, one in stage I). Conclusion A multi-disciplinary team work model is feasible in developing countries, and the renal tumors protocols basically from developed countries are safe in developing countries. China (dpeaa)DE-He213 developing country (dpeaa)DE-He213 multi-disciplinary team (dpeaa)DE-He213 renal tumors (dpeaa)DE-He213 Cai, Jiao-Yang verfasserin aut Xu, Min verfasserin aut Ye, Qi-Dong verfasserin aut Zhou, Min verfasserin aut Yin, Min-Zhi verfasserin aut Zhong, Yu-Min verfasserin aut Chen, Jing verfasserin aut Shen, Shu-Hong verfasserin aut Tang, Jing-Yan verfasserin aut Enthalten in World Journal of Pediatrics Springer-Verlag, 2008 11(2015), 4 vom: 11. Okt., Seite 326-330 (DE-627)SPR02598876X nnns volume:11 year:2015 number:4 day:11 month:10 pages:326-330 https://dx.doi.org/10.1007/s12519-015-0041-3 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_21 GBV_ILN_31 GBV_ILN_40 GBV_ILN_61 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_66 GBV_ILN_69 GBV_ILN_92 GBV_ILN_135 GBV_ILN_181 GBV_ILN_192 GBV_ILN_211 GBV_ILN_252 AR 11 2015 4 11 10 326-330 |
| allfieldsGer |
10.1007/s12519-015-0041-3 doi (DE-627)SPR025994387 (SPR)s12519-015-0041-3-e DE-627 ger DE-627 rakwb eng Pan, Ci verfasserin aut Renal tumor in developing countries: 142 cases from a single institution at Shanghai, China 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background The clinical management of children with renal tumors including Wilms’ tumor, clear cell sarcoma, rhabdoid tumor and other renal tumors in our center was designed according to the National Wilms’ Tumor Study Group protocols. Methods A total of 142 consecutive patients who had been diagnosed as having renal tumors at Shanghai Children’s Medical Center were reviewed retrospectively in the period of December 1998 and September 2012. Diagnosis and treatment were decided by a multidisciplinary team including oncologists, surgeons, pathologists and sub-specialized radiologists. Results The median age of the patients at the time of diagnosis was 27 months. The tumor stages of the patients were as follows: stage I 24.6%, stage II 23.2%, stage III 32.3%, stage IV 14.1%, and stage V 5.6%. Favorable histology was diagnosed in 80.3%, anaplasia in 4.2%, clear cell sarcoma in 9.8%, rhabdoid tumor in 4.9%, and other renal tumors in 0.7% of the patients. The eventfree and overall 5-year survival rates were 80% and 83%, respectively. Tumor relapse and progress was seen in 25 patients (17.6%). The median relapse time was 6 months (range: 2-37 months). Seven relapsing patients were retreated and four of them got second complete remission (three in stage II, one in stage I). Conclusion A multi-disciplinary team work model is feasible in developing countries, and the renal tumors protocols basically from developed countries are safe in developing countries. China (dpeaa)DE-He213 developing country (dpeaa)DE-He213 multi-disciplinary team (dpeaa)DE-He213 renal tumors (dpeaa)DE-He213 Cai, Jiao-Yang verfasserin aut Xu, Min verfasserin aut Ye, Qi-Dong verfasserin aut Zhou, Min verfasserin aut Yin, Min-Zhi verfasserin aut Zhong, Yu-Min verfasserin aut Chen, Jing verfasserin aut Shen, Shu-Hong verfasserin aut Tang, Jing-Yan verfasserin aut Enthalten in World Journal of Pediatrics Springer-Verlag, 2008 11(2015), 4 vom: 11. Okt., Seite 326-330 (DE-627)SPR02598876X nnns volume:11 year:2015 number:4 day:11 month:10 pages:326-330 https://dx.doi.org/10.1007/s12519-015-0041-3 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_21 GBV_ILN_31 GBV_ILN_40 GBV_ILN_61 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_66 GBV_ILN_69 GBV_ILN_92 GBV_ILN_135 GBV_ILN_181 GBV_ILN_192 GBV_ILN_211 GBV_ILN_252 AR 11 2015 4 11 10 326-330 |
| allfieldsSound |
10.1007/s12519-015-0041-3 doi (DE-627)SPR025994387 (SPR)s12519-015-0041-3-e DE-627 ger DE-627 rakwb eng Pan, Ci verfasserin aut Renal tumor in developing countries: 142 cases from a single institution at Shanghai, China 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background The clinical management of children with renal tumors including Wilms’ tumor, clear cell sarcoma, rhabdoid tumor and other renal tumors in our center was designed according to the National Wilms’ Tumor Study Group protocols. Methods A total of 142 consecutive patients who had been diagnosed as having renal tumors at Shanghai Children’s Medical Center were reviewed retrospectively in the period of December 1998 and September 2012. Diagnosis and treatment were decided by a multidisciplinary team including oncologists, surgeons, pathologists and sub-specialized radiologists. Results The median age of the patients at the time of diagnosis was 27 months. The tumor stages of the patients were as follows: stage I 24.6%, stage II 23.2%, stage III 32.3%, stage IV 14.1%, and stage V 5.6%. Favorable histology was diagnosed in 80.3%, anaplasia in 4.2%, clear cell sarcoma in 9.8%, rhabdoid tumor in 4.9%, and other renal tumors in 0.7% of the patients. The eventfree and overall 5-year survival rates were 80% and 83%, respectively. Tumor relapse and progress was seen in 25 patients (17.6%). The median relapse time was 6 months (range: 2-37 months). Seven relapsing patients were retreated and four of them got second complete remission (three in stage II, one in stage I). Conclusion A multi-disciplinary team work model is feasible in developing countries, and the renal tumors protocols basically from developed countries are safe in developing countries. China (dpeaa)DE-He213 developing country (dpeaa)DE-He213 multi-disciplinary team (dpeaa)DE-He213 renal tumors (dpeaa)DE-He213 Cai, Jiao-Yang verfasserin aut Xu, Min verfasserin aut Ye, Qi-Dong verfasserin aut Zhou, Min verfasserin aut Yin, Min-Zhi verfasserin aut Zhong, Yu-Min verfasserin aut Chen, Jing verfasserin aut Shen, Shu-Hong verfasserin aut Tang, Jing-Yan verfasserin aut Enthalten in World Journal of Pediatrics Springer-Verlag, 2008 11(2015), 4 vom: 11. Okt., Seite 326-330 (DE-627)SPR02598876X nnns volume:11 year:2015 number:4 day:11 month:10 pages:326-330 https://dx.doi.org/10.1007/s12519-015-0041-3 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_21 GBV_ILN_31 GBV_ILN_40 GBV_ILN_61 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_66 GBV_ILN_69 GBV_ILN_92 GBV_ILN_135 GBV_ILN_181 GBV_ILN_192 GBV_ILN_211 GBV_ILN_252 AR 11 2015 4 11 10 326-330 |
| language |
English |
| source |
Enthalten in World Journal of Pediatrics 11(2015), 4 vom: 11. Okt., Seite 326-330 volume:11 year:2015 number:4 day:11 month:10 pages:326-330 |
| sourceStr |
Enthalten in World Journal of Pediatrics 11(2015), 4 vom: 11. Okt., Seite 326-330 volume:11 year:2015 number:4 day:11 month:10 pages:326-330 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
China developing country multi-disciplinary team renal tumors |
| isfreeaccess_bool |
false |
| container_title |
World Journal of Pediatrics |
| authorswithroles_txt_mv |
Pan, Ci @@aut@@ Cai, Jiao-Yang @@aut@@ Xu, Min @@aut@@ Ye, Qi-Dong @@aut@@ Zhou, Min @@aut@@ Yin, Min-Zhi @@aut@@ Zhong, Yu-Min @@aut@@ Chen, Jing @@aut@@ Shen, Shu-Hong @@aut@@ Tang, Jing-Yan @@aut@@ |
| publishDateDaySort_date |
2015-10-11T00:00:00Z |
| hierarchy_top_id |
SPR02598876X |
| id |
SPR025994387 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR025994387</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20201125083906.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s12519-015-0041-3</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR025994387</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s12519-015-0041-3-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Pan, Ci</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Renal tumor in developing countries: 142 cases from a single institution at Shanghai, China</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background The clinical management of children with renal tumors including Wilms’ tumor, clear cell sarcoma, rhabdoid tumor and other renal tumors in our center was designed according to the National Wilms’ Tumor Study Group protocols. Methods A total of 142 consecutive patients who had been diagnosed as having renal tumors at Shanghai Children’s Medical Center were reviewed retrospectively in the period of December 1998 and September 2012. Diagnosis and treatment were decided by a multidisciplinary team including oncologists, surgeons, pathologists and sub-specialized radiologists. Results The median age of the patients at the time of diagnosis was 27 months. The tumor stages of the patients were as follows: stage I 24.6%, stage II 23.2%, stage III 32.3%, stage IV 14.1%, and stage V 5.6%. Favorable histology was diagnosed in 80.3%, anaplasia in 4.2%, clear cell sarcoma in 9.8%, rhabdoid tumor in 4.9%, and other renal tumors in 0.7% of the patients. The eventfree and overall 5-year survival rates were 80% and 83%, respectively. Tumor relapse and progress was seen in 25 patients (17.6%). The median relapse time was 6 months (range: 2-37 months). Seven relapsing patients were retreated and four of them got second complete remission (three in stage II, one in stage I). Conclusion A multi-disciplinary team work model is feasible in developing countries, and the renal tumors protocols basically from developed countries are safe in developing countries.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">China</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">developing country</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">multi-disciplinary team</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">renal tumors</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cai, Jiao-Yang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Xu, Min</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ye, Qi-Dong</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhou, Min</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yin, Min-Zhi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhong, Yu-Min</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chen, Jing</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Shen, Shu-Hong</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tang, Jing-Yan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">World Journal of Pediatrics</subfield><subfield code="d">Springer-Verlag, 2008</subfield><subfield code="g">11(2015), 4 vom: 11. Okt., Seite 326-330</subfield><subfield code="w">(DE-627)SPR02598876X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:11</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:4</subfield><subfield code="g">day:11</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:326-330</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s12519-015-0041-3</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_21</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_61</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_66</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_92</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_135</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_181</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_192</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_211</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_252</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">11</subfield><subfield code="j">2015</subfield><subfield code="e">4</subfield><subfield code="b">11</subfield><subfield code="c">10</subfield><subfield code="h">326-330</subfield></datafield></record></collection>
|
| author |
Pan, Ci |
| spellingShingle |
Pan, Ci misc China misc developing country misc multi-disciplinary team misc renal tumors Renal tumor in developing countries: 142 cases from a single institution at Shanghai, China |
| authorStr |
Pan, Ci |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)SPR02598876X |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut aut aut aut aut aut aut aut |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
Renal tumor in developing countries: 142 cases from a single institution at Shanghai, China China (dpeaa)DE-He213 developing country (dpeaa)DE-He213 multi-disciplinary team (dpeaa)DE-He213 renal tumors (dpeaa)DE-He213 |
| topic |
misc China misc developing country misc multi-disciplinary team misc renal tumors |
| topic_unstemmed |
misc China misc developing country misc multi-disciplinary team misc renal tumors |
| topic_browse |
misc China misc developing country misc multi-disciplinary team misc renal tumors |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
World Journal of Pediatrics |
| hierarchy_parent_id |
SPR02598876X |
| hierarchy_top_title |
World Journal of Pediatrics |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)SPR02598876X |
| title |
Renal tumor in developing countries: 142 cases from a single institution at Shanghai, China |
| ctrlnum |
(DE-627)SPR025994387 (SPR)s12519-015-0041-3-e |
| title_full |
Renal tumor in developing countries: 142 cases from a single institution at Shanghai, China |
| author_sort |
Pan, Ci |
| journal |
World Journal of Pediatrics |
| journalStr |
World Journal of Pediatrics |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2015 |
| contenttype_str_mv |
txt |
| container_start_page |
326 |
| author_browse |
Pan, Ci Cai, Jiao-Yang Xu, Min Ye, Qi-Dong Zhou, Min Yin, Min-Zhi Zhong, Yu-Min Chen, Jing Shen, Shu-Hong Tang, Jing-Yan |
| container_volume |
11 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Pan, Ci |
| doi_str_mv |
10.1007/s12519-015-0041-3 |
| author2-role |
verfasserin |
| title_sort |
renal tumor in developing countries: 142 cases from a single institution at shanghai, china |
| title_auth |
Renal tumor in developing countries: 142 cases from a single institution at Shanghai, China |
| abstract |
Background The clinical management of children with renal tumors including Wilms’ tumor, clear cell sarcoma, rhabdoid tumor and other renal tumors in our center was designed according to the National Wilms’ Tumor Study Group protocols. Methods A total of 142 consecutive patients who had been diagnosed as having renal tumors at Shanghai Children’s Medical Center were reviewed retrospectively in the period of December 1998 and September 2012. Diagnosis and treatment were decided by a multidisciplinary team including oncologists, surgeons, pathologists and sub-specialized radiologists. Results The median age of the patients at the time of diagnosis was 27 months. The tumor stages of the patients were as follows: stage I 24.6%, stage II 23.2%, stage III 32.3%, stage IV 14.1%, and stage V 5.6%. Favorable histology was diagnosed in 80.3%, anaplasia in 4.2%, clear cell sarcoma in 9.8%, rhabdoid tumor in 4.9%, and other renal tumors in 0.7% of the patients. The eventfree and overall 5-year survival rates were 80% and 83%, respectively. Tumor relapse and progress was seen in 25 patients (17.6%). The median relapse time was 6 months (range: 2-37 months). Seven relapsing patients were retreated and four of them got second complete remission (three in stage II, one in stage I). Conclusion A multi-disciplinary team work model is feasible in developing countries, and the renal tumors protocols basically from developed countries are safe in developing countries. |
| abstractGer |
Background The clinical management of children with renal tumors including Wilms’ tumor, clear cell sarcoma, rhabdoid tumor and other renal tumors in our center was designed according to the National Wilms’ Tumor Study Group protocols. Methods A total of 142 consecutive patients who had been diagnosed as having renal tumors at Shanghai Children’s Medical Center were reviewed retrospectively in the period of December 1998 and September 2012. Diagnosis and treatment were decided by a multidisciplinary team including oncologists, surgeons, pathologists and sub-specialized radiologists. Results The median age of the patients at the time of diagnosis was 27 months. The tumor stages of the patients were as follows: stage I 24.6%, stage II 23.2%, stage III 32.3%, stage IV 14.1%, and stage V 5.6%. Favorable histology was diagnosed in 80.3%, anaplasia in 4.2%, clear cell sarcoma in 9.8%, rhabdoid tumor in 4.9%, and other renal tumors in 0.7% of the patients. The eventfree and overall 5-year survival rates were 80% and 83%, respectively. Tumor relapse and progress was seen in 25 patients (17.6%). The median relapse time was 6 months (range: 2-37 months). Seven relapsing patients were retreated and four of them got second complete remission (three in stage II, one in stage I). Conclusion A multi-disciplinary team work model is feasible in developing countries, and the renal tumors protocols basically from developed countries are safe in developing countries. |
| abstract_unstemmed |
Background The clinical management of children with renal tumors including Wilms’ tumor, clear cell sarcoma, rhabdoid tumor and other renal tumors in our center was designed according to the National Wilms’ Tumor Study Group protocols. Methods A total of 142 consecutive patients who had been diagnosed as having renal tumors at Shanghai Children’s Medical Center were reviewed retrospectively in the period of December 1998 and September 2012. Diagnosis and treatment were decided by a multidisciplinary team including oncologists, surgeons, pathologists and sub-specialized radiologists. Results The median age of the patients at the time of diagnosis was 27 months. The tumor stages of the patients were as follows: stage I 24.6%, stage II 23.2%, stage III 32.3%, stage IV 14.1%, and stage V 5.6%. Favorable histology was diagnosed in 80.3%, anaplasia in 4.2%, clear cell sarcoma in 9.8%, rhabdoid tumor in 4.9%, and other renal tumors in 0.7% of the patients. The eventfree and overall 5-year survival rates were 80% and 83%, respectively. Tumor relapse and progress was seen in 25 patients (17.6%). The median relapse time was 6 months (range: 2-37 months). Seven relapsing patients were retreated and four of them got second complete remission (three in stage II, one in stage I). Conclusion A multi-disciplinary team work model is feasible in developing countries, and the renal tumors protocols basically from developed countries are safe in developing countries. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_21 GBV_ILN_31 GBV_ILN_40 GBV_ILN_61 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_66 GBV_ILN_69 GBV_ILN_92 GBV_ILN_135 GBV_ILN_181 GBV_ILN_192 GBV_ILN_211 GBV_ILN_252 |
| container_issue |
4 |
| title_short |
Renal tumor in developing countries: 142 cases from a single institution at Shanghai, China |
| url |
https://dx.doi.org/10.1007/s12519-015-0041-3 |
| remote_bool |
true |
| author2 |
Cai, Jiao-Yang Xu, Min Ye, Qi-Dong Zhou, Min Yin, Min-Zhi Zhong, Yu-Min Chen, Jing Shen, Shu-Hong Tang, Jing-Yan |
| author2Str |
Cai, Jiao-Yang Xu, Min Ye, Qi-Dong Zhou, Min Yin, Min-Zhi Zhong, Yu-Min Chen, Jing Shen, Shu-Hong Tang, Jing-Yan |
| ppnlink |
SPR02598876X |
| mediatype_str_mv |
c |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.1007/s12519-015-0041-3 |
| up_date |
2024-07-03T18:13:31.407Z |
| _version_ |
1803582608675700736 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR025994387</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20201125083906.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s12519-015-0041-3</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR025994387</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s12519-015-0041-3-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Pan, Ci</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Renal tumor in developing countries: 142 cases from a single institution at Shanghai, China</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background The clinical management of children with renal tumors including Wilms’ tumor, clear cell sarcoma, rhabdoid tumor and other renal tumors in our center was designed according to the National Wilms’ Tumor Study Group protocols. Methods A total of 142 consecutive patients who had been diagnosed as having renal tumors at Shanghai Children’s Medical Center were reviewed retrospectively in the period of December 1998 and September 2012. Diagnosis and treatment were decided by a multidisciplinary team including oncologists, surgeons, pathologists and sub-specialized radiologists. Results The median age of the patients at the time of diagnosis was 27 months. The tumor stages of the patients were as follows: stage I 24.6%, stage II 23.2%, stage III 32.3%, stage IV 14.1%, and stage V 5.6%. Favorable histology was diagnosed in 80.3%, anaplasia in 4.2%, clear cell sarcoma in 9.8%, rhabdoid tumor in 4.9%, and other renal tumors in 0.7% of the patients. The eventfree and overall 5-year survival rates were 80% and 83%, respectively. Tumor relapse and progress was seen in 25 patients (17.6%). The median relapse time was 6 months (range: 2-37 months). Seven relapsing patients were retreated and four of them got second complete remission (three in stage II, one in stage I). Conclusion A multi-disciplinary team work model is feasible in developing countries, and the renal tumors protocols basically from developed countries are safe in developing countries.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">China</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">developing country</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">multi-disciplinary team</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">renal tumors</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cai, Jiao-Yang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Xu, Min</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ye, Qi-Dong</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhou, Min</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yin, Min-Zhi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhong, Yu-Min</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chen, Jing</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Shen, Shu-Hong</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tang, Jing-Yan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">World Journal of Pediatrics</subfield><subfield code="d">Springer-Verlag, 2008</subfield><subfield code="g">11(2015), 4 vom: 11. Okt., Seite 326-330</subfield><subfield code="w">(DE-627)SPR02598876X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:11</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:4</subfield><subfield code="g">day:11</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:326-330</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s12519-015-0041-3</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_21</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_61</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_66</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_92</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_135</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_181</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_192</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_211</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_252</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">11</subfield><subfield code="j">2015</subfield><subfield code="e">4</subfield><subfield code="b">11</subfield><subfield code="c">10</subfield><subfield code="h">326-330</subfield></datafield></record></collection>
|
| score |
7.3998165 |